Table S1 from ANXA1 Binds and Stabilizes EGFR to Promote Nasopharyngeal Carcinoma Radioresistance

October 1, 2025

View at Publisher

Ask AI

Bookmark

Share

Key Points

ANXA1 binding to EGFR enhances radioresistance in nasopharyngeal carcinoma (NPC), indicating a critical role in cancer treatment response.
The study assesses clinicopathological characteristics of 124 NPC patients, yielding insights into factors affecting radioresistance.
An observational analysis of the clinicopathological features and radioresistance mechanisms in NPC highlights significant associations.
This finding suggests that targeting ANXA1-EGFR interactions could be vital for improving treatment outcomes in NPC patients.

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

This analysis finds that ANXA1 stabilizes EGFR, enhancing radioresistance in nasopharyngeal carcinoma, implying significant clinical implications.

Table S1. The clinicopathological characteristics of 124 patients with NPC

No takes yet. Share an insight, caveat, or question.

Zeng et al. (2025) studied this question.

View at Publisher

Ask AI

Bookmark

Share